ArticleIEEE access : practical innovations, open solutions2022
UVC-PURGE: A Novel Cost-Effective Disinfection Robot for Combating COVID-19 Pandemic.
Article in IEEE access : practical innovations, open solutions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 32 citations in OpenAlex.
- Review
- AnFrontiers in robotics and AI · 2025Article
- RoboCoV Cleaner: An Indoor Autonomous UV-C Disinfection Robot with Advanced Dual-Safety Systems.Sensors (Basel, Switzerland) · 2024Article
- UV Disinfection Robots: A Review.Robotics and autonomous systems · 2023Article
- Ultraviolet disinfection (UV-D) robots: bridging the gaps in dentistry.Frontiers in oral health · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
During the COVID-19 pandemic, surface disinfection using prevailing chemical disinfection methods had several limitations. Due to cost-inefficiency and the inability to disinfect shaded places, static UVC lamps cannot address these limitations properly. Moreover, the average market price of the prevailing UVC robots is huge, approximately 55,165 USD. In this research firstly, a requirement elicitation study was conducted using a semi-structured interview approach to reveal the requirements to develop a cost-effective UVC robot. Secondly, a semi-autonomous robot named UVC-PURGE was developed based on the revealed requirements. Thirdly, a two-phased evaluation study was undertaken to validate the effectiveness of UVC-PURGE to inactivate the SARS-CoV-2 virus and the capability of semi-autonomous navigation in the first phase and to evaluate the usability of the system through a hybrid approach of SUPR-Q forms and subjective evaluation of the user feedback in the second phase. Pre-treatment swab testing revealed the presence of both Gram-positive and Gram-Negative bacteria at 17 out of 20 test surfaces in the conducted tests. After the UVC irradiation of the robot, the microbial load was detected in only 2 (1D and 1H) out of 17 test surfaces with significant reductions (95.33% in 1D and 90.9% in 1H) of microbial load. Moreover, the usability evaluation yields an above-average SUPR-Q score of 81.91% with significant scores in all the criteria (usability, trust, loyalty, and appearance) and the number of positive themes from the subjective evaluation using thematic analysis is twice the number of negative themes. Additionally, compared with the prevailing UVC disinfection robots in the market, UVC-PURGE is cost-effective with a price of less than 800 USD. Moreover, small form factor along with the real time camera feedback in the developed system helps the user to navigate in congested places easily. The developed robot can be used in any indoor environment in this prevailing pandemic situation and it can also provide cost-effective disinfection in medical facilities against the long-term residual effect of COVID-19 in the post-pandemic era.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.